成功接受造血干细胞移植的Hurler综合征患者的生活质量
这项多中心队列研究纳入63例接受造血干细胞移植且随访至少3年的Hurler综合征患者,采用Child Health Questionnaire和Pediatric Outcomes Data Collection Instrument评估功能与心理社会健康,并与常模数据比较。患者功能健康显著低于常模,心理社会健康与健康同龄人相当或仅轻度降低,移植后获得的溶酶体酶水平较高预示功能健康更优。
要点
- 移植后Hurler综合征患者功能健康显著低于常模(躯体综合z评分中位数-2.4)。
- 心理社会健康与健康同龄人相当或仅轻度降低(心理社会综合z评分中位数0.15)。
- 移植后获得的溶酶体酶水平较高预示功能健康更优。
核心结论
- 移植后Hurler综合征患者功能健康较心理社会健康受影响更显著。
- 作者建议使用非携带者供者并力求达到完全供者嵌合,二者均带来更高酶水平,以改善功能健康。
- 评估健康相关生活质量可能对评价接受新型(细胞)疗法(包括自体基因转导造血干细胞移植)的Hurler综合征患者结局具有重要作用。
研究设计与样本
- 多中心队列研究,纳入63例接受造血干细胞移植且移植后随访至少3年的Hurler综合征患者。
- 采用Child Health Questionnaire和Pediatric Outcomes Data Collection Instrument评估功能与心理社会健康,并与常模数据比较。
- 采用Measure of Processes of Care问卷评估对照护的感知。
- 采用线性回归分析潜在预测因素的影响,采用Spearman秩相关进行相关分析。
主要发现
- 与常模数据相比,移植后Hurler综合征患者功能健康显著降低:躯体综合z评分中位数-2.4(范围-3.5至-1.6),总体功能z评分中位数-3.2(范围-4.8至-1.8)。
- 与健康同龄人相比,心理社会健康相当或仅轻度降低:心理社会综合z评分中位数0.15(范围-0.7至0.8)。
- 移植后获得的溶酶体酶水平较高预示功能健康更优。
- 总体上,家长对所接受的照护感到满意。
关键数值与推荐
- 功能健康:躯体综合z评分中位数-2.4(范围-3.5至-1.6),总体功能z评分中位数-3.2(范围-4.8至-1.8),均低于常模数据。
- 心理社会健康:心理社会综合z评分中位数0.15(范围-0.7至0.8),与健康同龄人相当或仅轻度降低。
临床怎么用
- 作者建议使用非携带者供者并力求达到完全供者嵌合,二者均带来更高酶水平,以改善功能健康。
- 作者认为评估健康相关生活质量可能对评价接受新型(细胞)疗法(包括自体基因转导造血干细胞移植)的Hurler综合征患者结局具有重要作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hurler syndrome (HS) is a lysosomal storage disease characterized by multisystem morbidity and death in early childhood. Hematopoietic stem cell transplantation (HSCT) results in long-term survival, although with significant residual disease burden. How this residual disease affects the health-related quality of life is unknown. Therefore, we conducted a multicenter cohort study on functional and psychosocial health and compared the outcomes to normative data using the Child Health Questionnaire and Pediatric Outcomes Data Collection Instrument. Perception of care was evaluated by the Measure of Processes of Care questionnaire. Sixty-three HS patients receiving HSCT with at least 3 years of follow-up after HSCT were included. The influence of potential predictors was analyzed using linear regression analysis, and correlation analysis was performed using Spearman rank correlation. Functional health of transplanted HS patients was significantly diminished compared with normative data (median physical summary z score, -2.4 [range, -3.5 to -1.6]; median global functioning z score, -3.2 [range, -4.8 to -1.8]). Psychosocial health was comparable or only slightly reduced compared with healthy peers (median psychosocial summary z score, 0.15 [range, -0.7 to 0.8]). A higher obtained lysosomal enzyme level post-HSCT predicted for superior functional health. Overall, parents were satisfied with the care received. Functional health of transplanted HS patients appeared significantly more affected than psychosocial health. To improve functional health, the use of only noncarrier donors and striving to achieve full-donor chimerism, both resulting in higher enzyme levels, is advised. Assessing the health-related quality of life could play an important role in evaluating outcomes of HS patients receiving novel (cell) therapies, including autologous gene-transduced HSCT.
引用
- Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017. PMID: 29296871. doi:10.1182/bloodadvances.2017011387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。